Head and neck cancer post-treatment clinical pathways for patients and relatives: hospital and patient organisations collaboration – feasibility study

[...]to our knowledge, this system has never been deployed in HNC. Since 2012, the cancer announcement process has been generalised at our institution for patients with HNC. All patients are offered a time of pretherapeutic paramedical support (called ‘temps d’accompagnement soignant 1’ (TAS 1), tha...

Full description

Saved in:
Bibliographic Details
Published inBMJ supportive & palliative care Vol. 14; no. e1; pp. e324 - e325
Main Authors Buiret, Guillaume, Hamant, Chloé, Lantheaume, Sophie
Format Journal Article
LanguageEnglish
Published England British Medical Journal Publishing Group 27.07.2022
BMJ Publishing Group LTD
BMJ Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:[...]to our knowledge, this system has never been deployed in HNC. Since 2012, the cancer announcement process has been generalised at our institution for patients with HNC. All patients are offered a time of pretherapeutic paramedical support (called ‘temps d’accompagnement soignant 1’ (TAS 1), that is, time for support by caregiver). Since June 2019, a work on post cancer is being conducted by our hospital, the Instance de Promotion et d'Education Pour la Santé Auvergne Rhône Alpes and five patient associations (Association des Mutilés de la Voix Rhône Alpes, Ligues de Lutte Contre le Cancer d'Ardèche et de la Drôme, Agir Contre le Cancer 26 and Cancer et Activité Physique Drôme Ardèche) allowing the networking of different key actors of the territory to improve the overall health of patients. Since October 2021, we have implemented the feasibility of a post-HNC health pathway and of which we present the main steps, tools and results.
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:2045-435X
2045-4368
DOI:10.1136/spcare-2022-003843